Krishna Institute of Medical Sciences Ltd (KIMS)

KIMS Acquires Multi-Specialty Hospitals in Andhra Pradesh - 10 Jul, 2024

Krishna Institute of Medical Sciences (KIMS) acquires Queens NRI Hospital and executes a share purchase agreement to acquire a 200-bed multi-specialty hospital in Vizag, increasing its total bed capacity to 630 beds. The acquisitions will help the company garner a larger share in the market. KIMS shares rally up to 4%.

KIMS Expects 15% Operating Profit Growth for FY25 - 09 Jul, 2024

Krishna Institute of Medical Sciences Ltd (KIMS) expects a 15% growth in operating profit for FY25, driven by ongoing expansion plans that will add 1,500 to 2,000 new beds and take the total bed capacity to 5,500 over the next 18 months. The number of operational beds will be around 4,000.

Krishna Institute of Medical Sciences Ltd Manages Debt Well - 02 Jul, 2024

Krishna Institute of Medical Sciences Limited (KIMS) has a net debt of about ₹9.14b, but its ability to cover interest expense with EBIT is noteworthy. KIMS' net debt is only 1.4 times its EBITDA and it operates in the defensive Healthcare industry.

KIMS Announces Stock Split, Shares Rise - 28 Jun, 2024

Krishna Institute of Medical Sciences Ltd has announced a stock split of one equity share into five with face values of Rs 2 each. The record date for the split will be intimated later. KIMS reported a 29.8% YoY fall in consolidated net profit to Rs 65.47 crore in Q4 FY24. However, revenue from operations rose by 10%. The scrip shed 0.25% to trade at Rs 2097.80 on BSE.

Krishna Institute of Medical Sciences Proposes Stock Split - 25 Jun, 2024

Krishna Institute of Medical Sciences Ltd. plans to split one equity share with a face value of ₹10 into five equity shares with a face value of ₹2 each, resulting in shareholders receiving 5 additional shares for each held share.

Prabhudas Lilladher Recommends Buy Rating for KIMS with Target Price of Rs 2200/Share - 18 Jun, 2024

Krishna Institute of Medical Sciences (KIMS) is expected to continue growing at double digits, driven by Sunshine and Nagpur units. The company plans to expand in Bengaluru and Maharashtra, aiming for faster breakeven and +25% OPM across new clusters over the next 4-5 years. KIMS EBITDA has grown at 21% CAGR over FY21-24, and operating cash flow of Rs12-13bn over FY24-26E will be used to set up new units.

KIMS Reports Strong Revenue Growth and Analyst Reiterates Accumulate Rating - 12 Jun, 2024

Krishna Institute of Medical Sciences Ltd reports strong Q4FY24 revenue growth and Geojit Financial Services reiterates an accumulate rating with a revised target price of Rs. 2,164.

Krishna Institute of Medical Sciences to Invest in Meda Institute of Podiatry - 11 Jun, 2024

Krishna Institute of Medical Sciences has signed an agreement to invest Rs. 1,02,00,000 in Meda Institute of Podiatry to set up and expand small podiatric hospital clusters in Hyderabad, India.